Bulletin
Investor Alert

New York Markets Close in:

GW Pharmaceuticals PLC ADR

NAS: GWPH

GO
/marketstate/country/us

Market open

 --Real time quotes

Sep 18, 2020, 2:10 p.m.

/zigman2/quotes/209686240/composite

$

99.71

Change

-2.30 -2.25%

Volume

Volume 448,187

Real time quotes

/zigman2/quotes/209686240/composite

Previous close

$ 102.01

$ 99.71

Change

-2.30 -2.25%

Day low

Day high

$98.65

$102.16

Open

52 week low

52 week high

$67.98

$141.98

Open

Insider Actions for GW Pharmaceuticals PLC ADR

– Purchase – Sale 1 – Number of Transactions
Date Name Shares Transaction Value
08/11/2020 Douglas B. Snyder
Chief Legal Officer
24,000   Disposition at $9.4 per share. 225,600
08/10/2020 Douglas B. Snyder
Chief Legal Officer
9,180   Derivative/Non-derivative trans. at $9.11 per share. 83,629
08/10/2020 Douglas B. Snyder
Chief Legal Officer
57,060   Derivative/Non-derivative trans. at $9.11 per share. 519,816
08/10/2020 Douglas B. Snyder
Chief Legal Officer
9,180   Derivative/Non-derivative trans. at $0 per share. 0
08/10/2020 Douglas B. Snyder
Chief Legal Officer
122,364   Derivative/Non-derivative trans. at $0 per share. 0
05/29/2020 Geoffrey William Guy
Executive Chairman; Director
600,000   Disposition at $10.24 per share. 6,144,000
05/29/2020 Geoffrey William Guy
Executive Chairman; Director
120,000   Disposition at $10.27 per share. 1,232,400
08/12/2019 Douglas B. Snyder
Chief Legal Officer
3,756   Disposition at $13.88 per share. 52,133

Transaction Summary

Total insider purchases and sales reported to the SEC

Timeframe Transactions Shares
Last 3 months
2 Purchases
3 Sales
131,544
90,240
Last 6 months
2 Purchases
5 Sales
131,544
810,240
Last 12 months
2 Purchases
5 Sales
131,544
810,240

Officers and Executives

Dr. Geoffrey William Guy
Chairman
Mr. Justin D. Gover
Chief Executive Officer & Executive Director
Mr. Christopher John Tovey
Chief Operating Officer
Mr. Scott M. Giacobello
CFO & Principal Accounting Officer
Dr. Volker Knappertz
Chief Medical Officer
Mr. Darren S. Cline
Chief Commercial Officer-United States
Mr. David W. Gryska
Director
Mr. Stephen D. Schultz
Vice President-Investor Relations
Ms. Tina St Leger
Chief Human Resource Officer
Mr. Adam David George
Secretary & Managing Director-UK
Mr. Douglas B. Snyder
Chief Legal Officer
Mr. James Julian Noble
Deputy Chairman
Mr. Cabot Brown
Independent Non-Executive Director
Dr. Catherine J. Mackey
Independent Non-Executive Director
Ms. Alicia Secor
Independent Non-Executive Director
Mr. William Arthur Waldegrave
Independent Non-Executive Director
Link to MarketWatch's Slice.